-
公开(公告)号:CA2722093C
公开(公告)日:2015-04-28
申请号:CA2722093
申请日:2009-05-28
Applicant: UCB PHARMA SA
Inventor: EECKMAN FREDERIC , BERWAER MONIQUE , FANARA DOMENICO
Abstract: The present invention relates to a pharmaceutical composition comprising brivaracetam as active ingredient, the invention relates specifically to a prolonged release formulation.
-
2.
公开(公告)号:EA019583B1
公开(公告)日:2014-04-30
申请号:EA201100753
申请日:2009-11-17
Applicant: UCB PHARMA SA
Inventor: FANARA DOMENICO , EECKMAN FREDERIC , BERWAER MONIQUE
IPC: A61K9/50 , A61K31/4015
Abstract: Впатентефармацевтическаякомпозиция, включающаяв качествеактивногоингредиентабриварацетамилиселетрацетам, атакжеболееподробнокомпозицияс пролонгированнымвысвобождением, котораяполученаизгранул, содержащихактивныйингредиентвовнутреннемядреуказаннойкомпозиции.
-
公开(公告)号:AU2009317280A1
公开(公告)日:2010-05-27
申请号:AU2009317280
申请日:2009-11-17
Applicant: UCB PHARMA SA
Inventor: FANARA DOMENICO , EECKMAN FREDERIC , BERWAER MONIQUE
IPC: A61K9/50 , A61K31/4015
-
公开(公告)号:CA2741041C
公开(公告)日:2015-01-13
申请号:CA2741041
申请日:2009-11-17
Applicant: UCB PHARMA SA
Inventor: FANARA DOMENICO , EECKMAN FREDERIC , BERWAER MONIQUE
IPC: A61K9/50 , A61K31/4015
Abstract: The present invention relates to a pharmaceutical composition comprising Levetiracetam, Brivaracetam or Seletracetam as active ingredient, the invention relates specifically to a prolonged release formulation.
-
公开(公告)号:CA2741038C
公开(公告)日:2015-01-13
申请号:CA2741038
申请日:2009-11-17
Applicant: UCB PHARMA SA
Inventor: FANARA DOMENICO , EECKMAN FREDERIC , BERWAER MONIQUE
IPC: A61K9/50 , A61K31/4015
Abstract: The present invention relates to a pharmaceutical composition comprising Brivaracetam or Seletracetam as active ingredient, the invention relates specifically to a prolonged release formulation made of granules containing the active ingredient in their inner core.
-
6.
公开(公告)号:MX2011004816A
公开(公告)日:2011-05-30
申请号:MX2011004816
申请日:2009-11-17
Applicant: UCB PHARMA SA
Inventor: FANARA DOMENICO , BERWAER MONIQUE , EECKMAN FREDERIC
IPC: A61K9/50 , A61K31/4015
Abstract: La presente invención se refiere a una composición farmacéutica que comprende Levetiracetam, Brivaracetam o Seletracetam como el ingrediente activo, la invención se refiere específicamente a una formulación de liberación prolongada.
-
公开(公告)号:CA2741041A1
公开(公告)日:2010-05-27
申请号:CA2741041
申请日:2009-11-17
Applicant: UCB PHARMA SA
Inventor: FANARA DOMENICO , EECKMAN FREDERIC , BERWAER MONIQUE
IPC: A61K9/50 , A61K31/4015
Abstract: The present invention relates to a pharmaceutical composition comprising Levetiracetam, Brivaracetam or Seletracetam as active ingredient, the invention relates specifically to a prolonged release formulation.
-
公开(公告)号:AU2009317279A1
公开(公告)日:2010-05-27
申请号:AU2009317279
申请日:2009-11-17
Applicant: UCB PHARMA SA
Inventor: FANARA DOMENICO , EECKMAN FREDERIC , BERWAER MONIQUE
IPC: A61K9/50 , A61K31/4015
Abstract: The present invention relates to a pharmaceutical composition comprising Brivaracetam or Seletracetam as active ingredient, the invention relates specifically to a prolonged release formulation made of granules containing the active ingredient in their inner core.
-
公开(公告)号:CA2722093A1
公开(公告)日:2009-12-03
申请号:CA2722093
申请日:2009-05-28
Applicant: UCB PHARMA SA
Inventor: EECKMAN FREDERIC , BERWAER MONIQUE , FANARA DOMENICO
Abstract: The present invention relates to a pharmaceutical composition comprising brivaracetam as active ingredient, the invention relates specifically to a prolonged release formulation.
-
公开(公告)号:CA2741038A1
公开(公告)日:2010-05-27
申请号:CA2741038
申请日:2009-11-17
Applicant: UCB PHARMA SA
Inventor: FANARA DOMENICO , EECKMAN FREDERIC , BERWAER MONIQUE
IPC: A61K9/50 , A61K31/4015
Abstract: The present invention relates to a pharmaceutical composition comprising Brivaracetam or Seletracetam as active ingredient, the invention relates specifically to a prolonged release formulation made of granules containing the active ingredient in their inner core.
-
-
-
-
-
-
-
-
-